Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5638-5647

  Peng, Dong Jun ^a,b   Zeng, Minghui ^a,b   Muromoto, Ryuta ^c   Matsuda, Tadashi ^c   Shimoda, Kazuya ^d   Subramaniam, Malayannan ^e   Spelsberg, Thomas C ^e   Wei, Wei Zen ^a,b   Venuprasad, K ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; KRUPPEL LIKE FACTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR TIEG1; TRANSFORMING GROWTH FACTOR BETA; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL NUCLEUS; CONTROLLED STUDY; IMMUNE RESPONSE; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; TH17 CELL; TUMOR GROWTH; TUMOR IMMUNITY; UBIQUITINATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADOPTIVE TRANSFER; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOPRECIPITATION; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TYK2 KINASE; UBIQUITINATION;

EID: 79956194738     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003801     Document Type: Article

References (66)

1. Sakaguchi, S., and F. Powrie. 2007. Emerging challenges in regulatory T cell function and biology. Science 317: 627-629. (Pubitemid 47229955)
2. Chen, W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady, and S. M. Wahl. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
3. Li, M. O., and R. A. Flavell. 2008. TGF-beta: a master of all T cell trades. Cell 134: 392-404.
4. Nishikawa, H., T. Kato, I. Tawara, K. Saito, H. Ikeda, K. Kuribayashi, P. M. Allen, R. D. Schreiber, S. Sakaguchi, L. J. Old, and H. Shiku. 2005. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. J. Exp. Med. 201: 681-686.
5. Nishikawa, H., T. Kato, K. Tanida, A. Hiasa, I. Tawara, H. Ikeda, Y. Ikarashi, H. Wakasugi, M. Kronenberg, T. Nakayama, et al. 2003. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc. Natl. Acad. Sci. USA 100: 10902-10906.
6. Liu, V. C., L. Y. Wong, T. Jang, A. H. Shah, I. Park, X. Yang, Q. Zhang, S. Lonning, B. A. Teicher, and C. Lee. 2007. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J. Immunol. 178: 2883-2892.
7. Zhang, Q., X. Yang, M. Pins, B. Javonovic, T. Kuzel, S. J. Kim, L. V. Parijs, N. M. Greenberg, V. Liu, Y. Guo, and C. Lee. 2005. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Cancer Res. 65: 1761-1769. (Pubitemid 40478602)
8. Shah, A. H., and C. Lee. 2000. TGF-beta-based immunotherapy for cancer: breaching the tumor firewall. Prostate 45: 167-172.
9. Teicher, B. A. 2001. Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev. 20: 133-143. (Pubitemid 34074689)
10. Massagué, J. 2008. TGFbeta in Cancer. Cell 134: 215-230.
11. Colombo, M. P., and S. Piconese. 2007. Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat. Rev. Cancer 7: 880-887.
12. Valzasina, B., S. Piconese, C. Guiducci, and M. P. Colombo. 2006. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Cancer Res. 66: 4488-4495.
13. Yang, Z. Z., A. J. Novak, S. C. Ziesmer, T. E. Witzig, and S. M. Ansell. 2007. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. Blood 110: 2537-2544.
14. Qin, F. X. 2009. Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host. Cell. Mol. Immunol. 6: 3-13.
15. Littman, D. R., and A. Y. Rudensky. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
16. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
17. Martin-Orozco, N., P. Muranski, Y. Chung, X. O. Yang, T. Yamazaki, S. Lu, P. Hwu, N. P. Restifo, W. W. Overwijk, and C. Dong. 2009. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787-798.
18. Muranski, P., A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373.
19. Hinrichs, C. S., A. Kaiser, C. M. Paulos, L. Cassard, L. Sanchez-Perez, B. Heemskerk, C. Wrzesinski, Z. A. Borman, P. Muranski, and N. P. Restifo. 2009. Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 114: 596-599.
20. Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282: 9358-9363.
21. Venuprasad, K., H. Huang, Y. Harada, C. Elly, M. Subramaniam, T. Spelsberg, J. Su, and Y. C. Liu. 2008. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9: 245-253.
22. Gao, M., and M. Karin. 2005. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol. Cell 19: 581-593. (Pubitemid 41219435)
23. Venuprasad, K. 2010. Cbl-b and itch: key regulators of peripheral T-cell tolerance. Cancer Res. 70: 3009-3012.
24. Li, M., C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu. 2003. Monoversus polyubiquitination: differential control of p53 fate by Mdm2. Science 302: 1972-1975. (Pubitemid 37523506)
25. Trotman, L. C., X. Wang, A. Alimonti, Z. Chen, J. Teruya-Feldstein, H. Yang, N. P. Pavletich, B. S. Carver, C. Cordon-Cardo, H. Erdjument-Bromage, et al. 2007. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128: 141-156. (Pubitemid 46048885)
26. Wang, X., L. C. Trotman, T. Koppie, A. Alimonti, Z. Chen, Z. Gao, J. Wang, H. Erdjument-Bromage, P. Tempst, C. Cordon-Cardo, et al. 2007. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128: 129-139. (Pubitemid 46048884)
27. Subramaniam, M., G. Gorny, S. A. Johnsen, D. G. Monroe, G. L. Evans, D. G. Fraser, D. J. Rickard, K. Rasmussen, J. M. van Deursen, R. T. Turner, et al. 2005. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol. Cell. Biol. 25: 1191-1199.
28. Shimoda, K., K. Kato, K. Aoki, T. Matsuda, A. Miyamoto, M. Shibamori, M. Yamashita, A. Numata, K. Takase, S. Kobayashi, et al. 2000. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity 13: 561-571.
29. Lim, K. L., K. C. Chew, J. M. Tan, C. Wang, K. K. Chung, Y. Zhang, Y. Tanaka, W. Smith, S. Engelender, C. A. Ross, et al. 2005. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25: 2002-2009. (Pubitemid 40289405)
30. Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798. (Pubitemid 24294454)
31. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
32. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, S. H. Chang, K. S. Schluns, S. S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56.
33. Korn, T., M. Mitsdoerffer, A. L. Croxford, A. Awasthi, V. A. Dardalhon, G. Galileos, P. Vollmar, G. L. Stritesky, M. H. Kaplan, A. Waisman, et al. 2008. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105: 18460-18465.
34. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
35. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322.
36. French, J. D., D. K. Walters, and D. F. Jelinek. 2003. Transactivation of gp130 in myeloma cells. J. Immunol. 170: 3717-3723.
37. Minegishi, Y., M. Saito, T. Morio, K. Watanabe, K. Agematsu, S. Tsuchiya, H. Takada, T. Hara, N. Kawamura, T. Ariga, et al. 2006. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755. (Pubitemid 46131400)
38. Milner, J. D., J. M. Brenchley, A. Laurence, A. F. Freeman, B. J. Hill, K. M. Elias, Y. Kanno, C. Spalding, H. Z. Elloumi, M. L. Paulson, et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773-776.
39. Nakamura, R., K. Shibata, H. Yamada, K. Shimoda, K. Nakayama, and Y. Yoshikai. 2008. Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by gammadelta T cells. J. Immunol. 181: 2071-2075.
40. Shaw, M. H., V. Boyartchuk, S. Wong, M. Karaghiosoff, J. Ragimbeau, S. Pellegrini, M. Muller, W. F. Dietrich, and G. S. Yap. 2003. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc. Natl. Acad. Sci. USA 100: 11594-11599.
41. Ortmann, R., R. Smeltz, G. Yap, A. Sher, and E. M. Shevach. 2001. A heritable defect in IL-12 signaling in B10.Q/J mice. I. In vitro analysis. J. Immunol. 166: 5712-5719.
42. Hunter, T. 2007. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28: 730-738. (Pubitemid 350217067)
43. Ben-Saadon, R., D. Zaaroor, T. Ziv, and A. Ciechanover. 2006. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol. Cell 24: 701-711. (Pubitemid 44839211)
44. Xu, P., D. M. Duong, N. T. Seyfried, D. Cheng, Y. Xie, J. Robert, J. Rush, M. Hochstrasser, D. Finley, and J. Peng. 2009. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137: 133-145.
45. Wang, H., A. Matsuzawa, S. A. Brown, J. Zhou, C. S. Guy, P. H. Tseng, K. Forbes, T. P. Nicholson, P. W. Sheppard, H. Häcker, et al. 2008. Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin. Proc. Natl. Acad. Sci. USA 105: 20197-20202.
46. Huang, H., M. S. Jeon, L. Liao, C. Yang, C. Elly, J. R. Yates, III, and Y. C. Liu. 2010. K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling. Immunity 33: 60-70.
47. Zou, W., and N. P. Restifo. 2010. T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10: 248-256.
48. Zhou, G., C. G. Drake, and H. I. Levitsky. 2006. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 107: 628-636.
49. Melief, C. J. 2008. Cancer immunotherapy by dendritic cells. Immunity 29: 372-383.
50. Welters, M. J., G. G. Kenter, S. J. Piersma, A. P. Vloon, M. J. Löwik, D. M. Berends-van der Meer, J. W. Drijfhout, A. R. Valentijn, A. R. Wafelman, J. Oostendorp, et al. 2008. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin. Cancer Res. 14: 178-187.
51. Sfanos, K. S., T. C. Bruno, C. H. Maris, L. Xu, C. J. Thoburn, A. M. DeMarzo, A. K. Meeker, W. B. Isaacs, and C. G. Drake. 2008. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin. Cancer Res. 14: 3254-3261.
52. Kottke, T., L. Sanchez-Perez, R. M. Diaz, J. Thompson, H. Chong, K. Harrington, S. K. Calderwood, J. Pulido, N. Georgopoulos, P. Selby, et al. 2007. Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res. 67: 11970-11979.
53. Cao, Z., A. K. Wara, B. Icli, X. Sun, R. R. Packard, F. Esen, C. J. Stapleton, M. Subramaniam, K. Kretschmer, I. Apostolou, et al. 2009. Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J. Biol. Chem. 284: 24914-24924.
54. Zhou, L., J. E. Lopes, M. M. Chong, I. I. Ivanov, R. Min, G. D. Victora, Y. Shen, J. Du, Y. P. Rubtsov, A. Y. Rudensky, et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240. (Pubitemid 351667978)
55. Mukhopadhyay, D., and H. Riezman. 2007. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315: 201-205. (Pubitemid 46166358)
56. Malynn, B. A., and A. Ma. 2010. Ubiquitin makes its mark on immune regulation. Immunity 33: 843-852.
57. Zucchelli, S., M. Codrich, F. Marcuzzi, M. Pinto, S. Vilotti, M. Biagioli, I. Ferrer, and S. Gustincich. 2010. TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains. Hum. Mol. Genet. 19: 3759-3770.
58. Ikeda, H., and T. K. Kerppola. 2008. Lysosomal localization of ubiquitinated Jun requires multiple determinants in a lysine-27-linked polyubiquitin conjugate. Mol. Biol. Cell 19: 4588-4601.
59. Taniguchi, E., F. Toyoshima-Morimoto, and E. Nishida. 2002. Nuclear translocation of plk1 mediated by its bipartite nuclear localization signal. J. Biol. Chem. 277: 48884-48888.
60. Mehta, T. S., H. Lu, X. Wang, A. M. Urvalek, K. H. Nguyen, F. Monzur, J. D. Hammond, J. Q. Ma, and J. Zhao. 2009. A unique sequence in the N-terminal regulatory region controls the nuclear localization of KLF8 by cooperating with the C-terminal zinc-fingers. Cell Res. 19: 1098-1109.
61. LaCasse, E. C., and Y. A. Lefebvre. 1995. Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res. 23: 1647-1656.
62. Skowyra, D., K. L. Craig, M. Tyers, S. J. Elledge, and J. W. Harper. 1997. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91: 209-219.
63. Kong, Y. C., G. P. Morris, N. K. Brown, Y. Yan, J. C. Flynn, and C. S. David. 2009. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J. Autoimmun. 33: 239-246.
64. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454: 350-352.
65. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T (H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-649.
66. Numasaki, M., J. Fukushi, M. Ono, S. K. Narula, P. J. Zavodny, T. Kudo, P. D. Robbins, H. Tahara, and M. T. Lotze. 2003. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627.